{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T10:10:20Z","timestamp":1770891020995,"version":"3.50.1"},"reference-count":49,"publisher":"China Science Publishing & Media Ltd.","issue":"12","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874312 and U1804197"],"award-info":[{"award-number":["81874312 and U1804197"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Foundation of Henan Province","award":["202300410308 2018GGJS102 18HASTIT047 ZD2020006 219906 and 192102310083"],"award-info":[{"award-number":["202300410308 2018GGJS102 18HASTIT047 ZD2020006 219906 and 192102310083"]}]},{"name":"Research Foundation of Xinxiang Medical University","award":["XYBSKYZZ201626 XYBSKYZZ505319 and YJSCX202041Y"],"award-info":[{"award-number":["XYBSKYZZ201626 XYBSKYZZ505319 and YJSCX202041Y"]}]}],"content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2021,10,1]]},"DOI":"10.1093\/abbs\/gmab150","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T19:41:15Z","timestamp":1633030875000},"page":"1691-1701","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":4,"title":["Vitamin B6 prevents Isocarbophos-induced posterior cerebral artery injury in offspring rats through up-regulating S1P receptor expression"],"prefix":"10.3724","volume":"53","author":[{"given":"Yanhua","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinfang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaling","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2026","published-online":{"date-parts":[[2021,10,30]]},"reference":[{"key":"null","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1096\/fj.01-0273rev","volume":"15","author":"Mertens A","year":"2001","unstructured":"Mertens A, Holvoet P. Oxidized LDL and HDL: antagonists in atherothrombosis. FASEB J, 2001, 15: 2073-2084.","journal-title":"FASEB J"},{"key":"null","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.envint.2013.08.008","volume":"60","author":"Berman T","year":"2013","unstructured":"Berman T, Goldsmith R, Goen T, Spungen J, Novack L, Levine H, Amitai Y. Urinary concentrations of organophosphate pesticide metabolites in adults in Israel: demograpHic and dietary predictors. Environ Int, 2013, 60: 183-189.","journal-title":"Environ Int"},{"key":"null","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1289\/ehp.10912","volume":"116","author":"Lu C","year":"2008","unstructured":"Lu C, Barr DB, Pearson MA, Waller LA. Dietary intake and its contribution to longitudinal organopHospHorus pesticide exposure in urban\/suburban children. Environ Health Perspect, 2008, 116: 537-542.","journal-title":"Environ Health Perspect"},{"key":"null","first-page":"176","volume":"39","author":"Soko\u0142owski R","year":"2015","unstructured":"Soko\u0142owski R, P\u0142usa T. Wspo\u0142czesne zagrozenie uzyciem zwi\u0105zkow fosforoorganicznych [Today\u2019s threat of use of organophosphorus compounds]. Pol Merkur Lekarski, 2015, 39: 176-180.","journal-title":"Pol Merkur Lekarski"},{"key":"null","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.tox.2018.09.009","volume":"410","author":"Jokanovic M","year":"2018","unstructured":"Jokanovic M. Neurotoxic effects of organophosphorus pesticides and possible association with neurodegenerative diseases in man: a review. Toxicology, 2018, 410: 125-131.","journal-title":"Toxicology"},{"key":"null","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.neuro.2010.12.008","volume":"32","author":"Rohlman DS","year":"2011","unstructured":"Rohlman DS, Anger WK, Lein PJ. Correlating neurobehavioral performance with biomarkers of organophosphorous pesticide exposure. Neurotoxicology, 2011, 32: 268-276.","journal-title":"Neurotoxicology"},{"key":"null","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/jcmm.12775","volume":"20","author":"Li P","year":"2016","unstructured":"Li P, Yin YL, Zhu ML, Pan GP, Zhao FR, Lu JX, Liu Z. Chronic administration of Isocarbophos induces vascular cognitive impairment in rats. Cell Mol Med, 2016, 20: 731-739.","journal-title":"Cell Mol Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"12639","DOI":"10.1073\/pnas.0807062105","volume":"105","author":"Chambers JE","year":"2008","unstructured":"Chambers JE. PON1 multitasks to protect health. Proc Natl Acad Sci USA, 2008, 105: 12639-12640.","journal-title":"Proc Natl Acad Sci USA"},{"key":"null","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0891-5849(02)01429-6","volume":"34","author":"Rozenberg O","year":"2003","unstructured":"Rozenberg O, Rosenblat M, Coleman R, Shih DM, Aviram M. Paraoxonase (PON1) deficiency is associated with increased macropHage oxidative stress: studies in PON1-knockout mice. Free Radic Biol Med, 2003, 34: 774-784.","journal-title":"Free Radic Biol Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1124\/jpet.109.155176","volume":"331","author":"Yang TT","year":"2009","unstructured":"Yang TT, Wang SJ. Pyridoxine inhibits depolarization-evoked glutamate release in nerve terminals from rat cerebral cortex: a possible neuroprotective mechanism. J Pnarmacol Exp Ther, 2009, 331: 244-254.","journal-title":"J Pnarmacol Exp Ther"},{"key":"null","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/ana.21568","volume":"65","author":"Gallagher RC","year":"2009","unstructured":"Gallagher RC, Van Hove JL, Scharer G, Hyland K, Plecko B, Waters PJ, Mercimek-Mahmutoglu S. Folinic acid-responsive seizures are identical to pyridoxine-dependent epilepsy. Ann Neurol, 2009, 65: 550-556.","journal-title":"Ann Neurol"},{"key":"null","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mam.2016.08.001","volume":"53","author":"Ueland PM","year":"2017","unstructured":"Ueland PM, McCann A, Midttun \u00d8, Ulvik A. Inflammation, vitamin B6 and related pathways. Mol Aspects Med, 2017, 53: 10-27.","journal-title":"Mol Aspects Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S0007114511000407","volume":"106","author":"Lotto V","year":"2011","unstructured":"Lotto V, Choi SW, Friso S. Vitamin B6: a challenging link between nutrition and inflammation in CVD. Br J Nutr, 2011, 106: 183-195.","journal-title":"Br J Nutr"},{"key":"null","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jama.279.5.359","volume":"279","author":"Rimm EB","year":"1998","unstructured":"Rimm EB, Willett WC, Hu FB, Sampson I, Colditz GA, Manson G, Hennekens C. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA, 1998, 279: 359-364.","journal-title":"JAMA"},{"key":"null","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/10641963.2017.1356844","volume":"40","author":"Li P","year":"2018","unstructured":"Li P, Zhu ML, Pan GP, Lu JX, Zhao FR, Jian X, Liu LY. Vitamin B6 prevents isocarbophos-induced vascular dementia in rats through N-methyl-D-aspartate receptor signaling. Clin Exp Hypertens, 2018, 40: 192-201.","journal-title":"Clin Exp Hypertens"},{"key":"null","volume":"2016","author":"Zhao L","year":"2016","unstructured":"Zhao L, Peng L, Zhao ZH, Zhang Y, Wang SX. Vitamin B6 prevents endothelial dysfunction, insulin resistance, and hepatic lipid accumulation in Apoe (-\/-) mice fed with high-fat diet. J Diabetes Res, 2016, 2016:","journal-title":"J Diabetes Res"},{"key":"null","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.02.009","volume":"154","author":"Stepanovska B","year":"2020","unstructured":"Stepanovska B, Huwiler A. Targeting the S1P receptor signaling pathways as a promising approach for treatment of autoimmune and inflammatory diseases. Pharmacol Res, 2020, 154:","journal-title":"Pharmacol Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nri2974","volume":"11","author":"Spiegel S","year":"2011","unstructured":"Spiegel S, Milstien S. The outs and the ins of sphingosine-1-phosphate in immunity. Nat Rev Immunol, 2011, 11: 403-415.","journal-title":"Nat Rev Immunol"},{"key":"null","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrd2356","volume":"8","author":"Marsolais D","year":"2009","unstructured":"Marsolais D, Rosen H. Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules. Nat Rev Drug Discov, 2009, 8: 297-307.","journal-title":"Nat Rev Drug Discov"},{"key":"null","doi-asserted-by":"crossref","DOI":"10.1126\/science.aar5551","volume":"366","author":"Cartier A","year":"2019","unstructured":"Cartier A, Hla T. Sphingosine 1-phosphate: lipid signaling in pathology and therapy. Science, 2019, 366:","journal-title":"Science"},{"key":"null","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nri2400","volume":"8","author":"Rivera J","year":"2008","unstructured":"Rivera J, Proia RL, Olivera A. The alliance of sphingosine-1-phosphate and its receptors in immunity. Nat Rev Immunol, 2008, 8: 753-763.","journal-title":"Nat Rev Immunol"},{"key":"null","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/WNF.0b013e3181cbf825","volume":"33","author":"Chun J","year":"2010","unstructured":"Chun J, Hartung HP. Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis. Clin Neuropharmacol, 2010, 33: 91-101.","journal-title":"Clin Neuropharmacol"},{"key":"null","first-page":"213","volume":"12","author":"Chun J","year":"2011","unstructured":"Chun J, Brinkmann V. A mechanistically novel, first oral therapy for multiple sclerosis: the development of fingolimod (FTY720, Gilenya). Discov Med, 2011, 12: 213-228.","journal-title":"Discov Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1053\/j.tcam.2016.05.001","volume":"31","author":"Gonzalez AL","year":"2016","unstructured":"Gonzalez AL, Waddell LS. Blood gas analyzers. Top Companion Anim Med, 2016, 31: 27-34.","journal-title":"Top Companion Anim Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/10641963.2017.1356844","volume":"40","author":"Peng L","year":"2018","unstructured":"Peng L, Zhu ML, Pan GP, Lu JX, Zhao FR, Jian X, Liu LY. Vitamin B6 prevents isocarbophos-induced vascular dementia in rats through N-methyl-D-aspartate receptor signaling. Clin Exp Hypertens, 2018, 40: 192-201.","journal-title":"Clin Exp Hypertens"},{"key":"null","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/jcmm.12775","volume":"20","author":"Li P","year":"2016","unstructured":"Li P, Yin YL, Zhu ML, Pan GP, Zhao FR, Lu JX, Liu Z. Chronic administration of isocarbophos induces vascular cognitive impairment in rats. J Cell Mol Med, 2016, 20: 731-739.","journal-title":"J Cell Mol Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/0014-4800(92)90031-6","volume":"56","author":"Julka D","year":"1992","unstructured":"Julka D, Pal R, Gill KD. Neurotoxicity of dichlorvos: effect on antioxidant defense system in the rat central nervous system. Exp Mol Pathol, 1992, 56: 144-152.","journal-title":"Exp Mol Pathol"},{"key":"null","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/BF03178266","volume":"5","author":"Shadnia S","year":"2009","unstructured":"Shadnia S, Okazi A, Akhlaghi N, Sasanian G, Abdollahi M. Prognostic value of long QT interval in acute and severe organophosphate poisoning. J Med Toxicol, 2009, 5: 196-199.","journal-title":"J Med Toxicol"},{"key":"null","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.clinbiochem.2008.06.009","volume":"41","author":"Kotur-Stevuljevic J","year":"2008","unstructured":"Kotur-Stevuljevic J, Spasic S, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V, Stefanovic A, Vujovic A, Memon L. PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients. Clin Biochem, 2008, 41: 1067-1073.","journal-title":"Clin Biochem"},{"key":"null","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1081\/DCT-120027900","volume":"27","author":"Tuovinen K","year":"2004","unstructured":"Tuovinen K. Function of plasma and microsomal enzymes in soman toxicity. Drug Chem Toxicol, 2004, 27: 69-75.","journal-title":"Drug Chem Toxicol"},{"key":"null","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11010-011-1154-1","volume":"363","author":"Liu X","year":"2012","unstructured":"Liu X, Zhang QH, Yi GH. Regulation of metabolism and transport of sphingosine-1-phosphate in mammalian cells. Mol Cell Biochem, 2012, 363: 21-33.","journal-title":"Mol Cell Biochem"},{"key":"null","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1042\/CS20110236","volume":"121","author":"Selim S","year":"2011","unstructured":"Selim S, Sunkara M, Salous AK, Leung SW, Berdyshev EV, Bailey A, Campbell CL. Plasma levels of sphingosine 1-phosphate are strongly correlated with haematocrit, but variably restored by red blood cell transfusions. Clin Sci, 2011, 121: 565-572.","journal-title":"Clin Sci"},{"key":"null","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/MCA.0b013e328351ab0a","volume":"23","author":"Sugiura T","year":"2012","unstructured":"Sugiura T, Dohi Y, Yamashita S, Ohte N, Ito S, Iwaki S, Hirowatari Y. Analytical evaluation of plasma serotonin and sphingosine 1-phosphate and their clinical assessment in early atherosclerosis. Coron Artery Dis, 2012, 23: 234-238.","journal-title":"Coron Artery Dis"},{"key":"null","first-page":"601","volume":"62","author":"Knapp M","year":"2011","unstructured":"Knapp M. Cardioprotective role of sphingosine-1-phosphate. J Physiol Pharmacol, 2011, 62: 601-607.","journal-title":"J Physiol Pharmacol"},{"key":"null","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/01.RES.0000122383.60368.24","volume":"94","author":"Saba JD","year":"2004","unstructured":"Saba JD, Hla T. Point-counterpoint of sphingosine 1-phosphate metabolism. Circ Res, 2004, 94: 724-734.","journal-title":"Circ Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehp387","volume":"31","author":"Brakch N","year":"2010","unstructured":"Brakch N, Dormond O, Bekri S, Golshayan D, Correvon M, Mazzolai L, Steinmann B. Evidence for a role of sphingosine-1 phosphate in cardiovascular remodelling in Fabry disease. Eur Heart J, 2010, 31: 67-76.","journal-title":"Eur Heart J"},{"key":"null","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/cvr\/cvn002","volume":"78","author":"Oyama O","year":"2008","unstructured":"Oyama O, Sugimoto N, Qi X, Takuwa N, Mizugishi K, Koizumi J, Takuwa Y. The lysophospholipid mediator sphingosine-1-phosphate promotes angiogenesis in vivo in ischaemic hindlimbs of mice. Cardiovasc Res, 2008, 78: 301-307.","journal-title":"Cardiovasc Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/sj.bjp.0705934","volume":"143","author":"Alewijnse AE","year":"2004","unstructured":"Alewijnse AE, Peters SL, Michel MC. Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites. Br J Pharmacol, 2004, 143: 666-684.","journal-title":"Br J Pharmacol"},{"key":"null","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-2796.1996.502836000.x","volume":"240","author":"Jendle JH","year":"1996","unstructured":"Jendle JH, Karlberg BE. Intrapulmonary administration of insulin to healthy volunteers. J Intern Med, 1996, 240: 93-98.","journal-title":"J Intern Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1172\/JCI10905","volume":"106","author":"Liu Y","year":"2000","unstructured":"Liu Y, Wada R, Yamashita T, Mi Y, Deng CX, Hobson JP, Rosenfeldt HM. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J Clin Invest, 2000, 106: 951-961.","journal-title":"J Clin Invest"},{"key":"null","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0092-8674(00)81661-X","volume":"99","author":"Lee MJ","year":"1999","unstructured":"Lee MJ, Thangada S, Claffey KP, Ancellin N, Liu CH, Kluk M, Volpi M. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell, 1999, 99: 301-312.","journal-title":"Cell"},{"key":"null","doi-asserted-by":"crossref","first-page":"19672","DOI":"10.1074\/jbc.M009993200","volume":"276","author":"Morales-Ruiz M","year":"2001","unstructured":"Morales-Ruiz M, Lee MJ, Zollner S, Gratton JP, Scotland R, Shiojima I, Walsh K. Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein\/phosphoinositide 3-kinase pathway in endothelial cells. J Biol Chem, 2001, 276: 19672-19677.","journal-title":"J Biol Chem"},{"key":"null","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1006\/taap.2000.8997","volume":"168","author":"Carlson K","year":"2000","unstructured":"Carlson K, Jortner BS, Ehrich M. Organophosphorus compound-induced apoptosis in SH-SY5Y human neuroblastoma cells. Toxicol Appl Pharmacol, 2000, 168: 102-113.","journal-title":"Toxicol Appl Pharmacol"},{"key":"null","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1043-6618(03)00046-X","volume":"47","author":"Cartier A","year":"2003","unstructured":"Cartier A, Hla T. Signaling and biological actions of sphingosine 1-phosphate. Pharmacol Res, 2003, 47: 401-407.","journal-title":"Pharmacol Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0008-6363(03)00260-8","volume":"58","author":"Ohmori T","year":"2003","unstructured":"Ohmori T, Yatomi Y, Osada M, Kazama F, Takafuta T, Ikeda H, Ozaki Y. Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2. Cardiovasc Res, 2003, 58: 170-177.","journal-title":"Cardiovasc Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/01.RES.0000028150.51130.36","volume":"91","author":"Coussin F","year":"2002","unstructured":"Coussin F, Scott RH, Wise A, Nixon GF. Comparison of sphingosine 1-phosphate-induced intracellular signaling pathways in vascular smooth muscles: differential role in vasoconstriction. Circ Res, 2002, 91: 151-157.","journal-title":"Circ Res"},{"key":"null","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-44845-5","volume":"9","author":"Salas-Perdomo A","year":"2019","unstructured":"Salas-Perdomo A, Miro-Mur F, Gallizioli M, Brait VH, Justicia C, Meissner A, Urra X. Role of the S1P pathway and inhibition by fingolimod in preventing hemorrhagic transformation after stroke. Sci Rep, 2019, 9:","journal-title":"Sci Rep"},{"key":"null","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharmthera.2017.11.001","volume":"185","author":"Huwiler A","year":"2018","unstructured":"Huwiler A, Zangemeister-Wittke U. The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: recent findings and new perspectives. Pharmacol Ther, 2018, 185: 34-49.","journal-title":"Pharmacol Ther"},{"key":"null","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.atherosclerosis.2004.07.032","volume":"178","author":"Tamama K","year":"2005","unstructured":"Tamama K, Tomura H, Sato K, Malchinkhuu E, Damirin A, Kimura T, Kuwabara A. High-density lipoprotein inhibits migration of vascular smooth muscle cells through its sphingosine 1-phosphate component. Atherosclerosis, 2005, 178: 19-23.","journal-title":"Atherosclerosis"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/12DC2F3713E44648B5B02A52E5B5982A","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmab150","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/abbs\/article-pdf\/53\/12\/1691\/41689560\/gmab150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/12DC2F3713E44648B5B02A52E5B5982A","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T21:22:50Z","timestamp":1673385770000},"score":1,"resource":{"primary":{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmab150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":49,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,10,30]]},"published-print":{"date-parts":[[2021,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/abbs\/gmab150","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,1]]}}}